Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company's bivalent ...
Provention Bio Competitors or Alternatives
Provention Bio's top competitors include Anokion, AnTolRx and Selecta.
Provention Bio VS Anokion
Anokion has been one of Provention Bio's top competitors. Anokion's headquarters is in Ecublens, Vaud, and was founded in 2010. Like Provention Bio, Anokion also competes in the Pharmaceuticals & Biotechnology field. Anokion generates 38% of Provention Bio's revenue.
Provention Bio VS AnTolRx
AnTolRx is one of Provention Bio's top rivals. AnTolRx is a Private company that was founded in Cambridge, Massachusetts in 2014. Like Provention Bio, AnTolRx also works within the Pharmaceuticals industry. AnTolRx has 129 fewer employees vs. Provention Bio.
Provention Bio VS Selecta
Selecta is perceived as one of Provention Bio's biggest rivals. Selecta was founded in 2007, and is headquartered in Gaithersburg, Maryland. Like Provention Bio, Selecta also competes in the Pharmaceuticals & Biotechnology sector. Selecta generates $13M more revenue vs. Provention Bio.
Looking for similar companies to Provention Bio?
Similar Companies
Companies in Red Bank with employees in 100-250 range
See 43 companies
Pharmaceuticals companies in New JerseySee 708 companies
Companies in Red Bank with revenue in $5.0-25M rangeSee 299 companies
Pharmaceuticals companies with employees in 100-250 rangeSee 813 companies
Pharmaceuticals companies in New York Metropolitan AreaSee 1,035 companies
Pharmaceuticals & Biotechnology companies in New JerseySee 1,085 companies
Pharmaceuticals & Biotechnology companies in New York Metropolitan AreaSee 1,762 companies
Pharmaceuticals & Biotechnology companies with employees in 100-250 rangeSee 1,792 companies
Pharmaceuticals companies with revenue in $5.0-25M rangeSee 2,473 companies
Trending News for Provention Bio and Provention Bio's Competitors
CAMBRIDGE, Mass. , March 31, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that company management will participa...
The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor. The post Eli Lilly's lepodi...
Flagship Pioneering, announced an agreement between Pioneering Medicines, Flagship's in-house drug discovery and development unit, and Pfizer, to disco...
Eli Lilly's RNA candidate has reduced levels of a protein linked with cardiovascular disease risk in a mid-stage trial in patients with high cholestero...
Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a cardioprotective benefit ...
Eli Lilly's lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk f...
/PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2025 financial results on Friday, April 25, 2025, before the market opens. AbbVie w...
Frequently Asked Questions about Provention Bio
Who are Provention Bio's top competitors?
Provention Bio's top 3 competitors are Anokion, AnTolRx, Selecta.Who is similar to Provention Bio?
Anokion is the most similar to Provention Bio. AnTolRx and Selecta are also similar to Provention Bio.
Are Provention Bio and Anokion competitors?
Yes, Anokion is one of Provention Bio’s top competitors.